Anti-EGLN2

Anti-EGLN2
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ATA-HPA075526.25 25 µl

7 - 10 Werktage*

330,00 €
ATA-HPA075526.100 100 µl

7 - 10 Werktage*

463,00 €
 
Rabbit Polyclonal EGLN2 Antibody against Human egl-9 family hypoxia inducible factor 2. Validated... mehr
Produktinformationen "Anti-EGLN2"
Rabbit Polyclonal EGLN2 Antibody against Human egl-9 family hypoxia inducible factor 2. Validated for Western Blot. Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Interspecies information: Highest antigen sequence indentity to the following orthologs: ENSMUSG00000058709: 78%, ENSRNOG00000020947: 79%. Protein function: Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as ATF4, IKBKB, CEP192 and HIF1A (PubMed:11595184, PubMed:12039559, PubMed:15925519, PubMed:16509823, PubMed:17114296, PubMed:23932902). Target proteins are preferentially recognized via a LXXLAP motif (PubMed:11595184, PubMed:12039559, PubMed:15925519). Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519, PubMed:19339211). Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519). Also hydroxylates HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Has a preference for the CODD site for both HIF1A and HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex (PubMed:11595184, PubMed:12039559, PubMed:15925519). Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy- inducible genes (PubMed:11595184, PubMed:12039559, PubMed:15925519). EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle (PubMed:11595184, PubMed:12039559, PubMed:15925519). Also regulates susceptibility to normoxic oxidative neuronal death (PubMed:11595184, PubMed:12039559, PubMed:15925519). Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation (PubMed:23932902). Hydroxylates IKBKB, mediating NF-kappa-B activation in hypoxic conditions (PubMed:17114296). Also mediates hydroxylation of ATF4, leading to decreased protein stability of ATF4. [The UniProt Consortium]
Schlagworte: Anti-PHD1, Anti-EIT-6, Anti-HPH-3, Anti-HPH-1, Anti-HIF-PH1, Anti-Egl nine homolog 2, Anti-Estrogen-induced tag 6, Anti-Prolyl hydroxylase EGLN2, Anti-HIF-prolyl hydroxylase 1, Anti-Hypoxia-inducible factor prolyl hydroxylase 1
Hersteller: Atlas Antibodies
Hersteller-Nr: HPA075526

Eigenschaften

Anwendung: WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: PLSQALPQLP GSSSEPLEPE PGRARMGVES YLPCPLLPSY HCPGVPSEAS AGSGTPRATA TSTTASPLRD
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C (+4 °C for short term storage)
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-EGLN2"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen